Skip to main content
OpenTrials

Clinical trial condition

Age-Related Macular Degeneration

Explore clinical trials studying Age-Related Macular Degeneration. Study availability and eligibility vary by location and protocol.

286 public trials 39 recruiting studies
Refine in advanced search Browse all conditions

Age-Related Macular Degeneration trial results

Completed

Study Assessing the Efficacy and Safety of Intravitreal Injections of DE-122 in Combination With Lucentis® Compared to Lucentis® Monotherapy in Wet Age-related Macular Degeneration Subjects

NCT03211234

Conditions
Age-Related Macular Degeneration, Eye Diseases, Macular Degeneration, +2 more
Locations
  • Retina Research Institute Gilbert, Arizona, United States
  • Retina-Vitreous Associates Beverly Hills, California, United States
  • Northern California Retina Vitreous Associates Mountain View, California, United States
  • Bay Area Retina Associates Walnut Creek, California, United States
View all 14 locations
View Trial Details
Completed

A Study to Compare SB11 (Proposed Ranibizumab Biosimilar) to Lucentis in Subjects With Neovascular Age-related Macular Degeneration (AMD)

NCT03150589

Conditions
Age-Related Macular Degeneration, Eye Diseases, Macular Degeneration, +2 more
Locations
  • Retina consultants San Diego Poway, California, United States
  • Retina Consultants of Southern Colorado Colorado Springs, Colorado, United States
  • Retina Consultants Fort Myers, Florida, United States
  • Southeast Retina Center Augusta, Georgia, United States
View all 75 locations
View Trial Details
Completed

RBM-007 in Subjects witH ExudatIve Age-related Macular Degeneration

NCT03633084

Conditions
Age-Related Macular Degeneration, Eye Diseases, Macular Degeneration, +2 more
Locations
  • Retinal Consultants Medical Group Sacramento, California, United States
  • Retinal Consultants Medical Group Sacramento, California, United States
  • Stanford University Stanford, California, United States
  • Bay Area Retina Associates Walnut Creek, California, United States
View Trial Details
Completed

Intravitreal LFG316 in Patients With Age-related Macular Degeneration (AMD)

NCT01527500

Conditions
Age-Related Macular Degeneration, Blindness, Eye Diseases, +10 more
Locations
  • Novartis Investigative Site Phoenix, Arizona, United States
  • Novartis Investigative Site Phoenix, Arizona, United States
  • Novartis Investigative Site Tucson, Arizona, United States
  • Novartis Investigative Site Beverly Hills, California, United States
View all 19 locations
View Trial Details

Related conditions